Search Results - "Skarbek, Charles"

Refine Results
  1. 1

    Camouflaging endovascular stents with an endothelial coat using CD31 domain 1 and 2 mimetic peptides by Sénémaud, Jean, Skarbek, Charles, Hernandez, Belen, Song, Ran, Lefevre, Isabelle, Bianchi, Elisabetta, Castier, Yves, Nicoletti, Antonino, Bureau, Christophe, Caligiuri, Giuseppina

    Published in JVS-vascular science (2024)
    “…Implantation of an endovascular device disrupts the homeostatic CD31:CD31 interactions among quiescent endothelial cells (ECs), platelets, and circulating…”
    Get full text
    Journal Article
  2. 2

    Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects by Delahousse, Julia, Skarbek, Charles, Desbois, Mélanie, Perfettini, Jean-Luc, Chaput, Nathalie, Paci, Angelo

    Published in Journal for immunotherapy of cancer (11-08-2020)
    “…BackgroundOxazaphosphorines (cyclophosphamide (CPA), ifosfamide (IFO)) are major alkylating agents of polychemotherapy protocols but limiting their toxicity…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment by Maslah, Hichem, Skarbek, Charles, Pethe, Stéphanie, Labruère, Raphaël

    Published in European journal of medicinal chemistry (01-12-2020)
    “…Boronic acid (and ester) prodrugs targeting the overexpressed level of reactive oxygen species within tumor microenvironment represent a promising area for the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Synthesis of 6-methylphenanthridines and evaluation against human papillomavirus-related endocervical adenocarcinoma (KB 3.1) cells by Maslah, Hichem, Skarbek, Charles, Labruère, Raphaël

    Published in Phytochemistry letters (01-04-2023)
    “…This study describes the synthesis of a series of 6-methylphenanthridines and their evaluation as cytotoxic agents. An unprecedented one-pot synthesis…”
    Get full text
    Journal Article
  7. 7
  8. 8

    In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development by Maslah, Hichem, Skarbek, Charles, Gourson, Catherine, Plamont, Marie‐Aude, Pethe, Stéphanie, Jullien, Ludovic, Le Saux, Thomas, Labruère, Raphaël

    Published in Angewandte Chemie International Edition (02-11-2021)
    “…Pharmacological inactivation of antitumor drugs toward healthy cells is a critical factor in prodrug development. Typically, pharmaceutical chemists graft…”
    Get full text
    Journal Article
  9. 9

    Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer by Skarbek, Charles, Serra, Silvia, Maslah, Hichem, Rascol, Estelle, Labruère, Raphaël

    Published in Bioorganic chemistry (01-10-2019)
    “…[Display omitted] •Arylboronate-doxorubicin conjugates as anticancer ROS-responsive prodrugs were synthesized.•In vitro cytotoxicity of the prodrugs and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Re-designing environmentally persistent pharmaceutical pollutant through programmed inactivation: The case of methotrexate by Espinosa, Anaïs, Rascol, Estelle, Abellán Flos, Marta, Skarbek, Charles, Lieben, Pascale, Bannerman, Eva, Martinez, Alba Diez, Pethe, Stéphanie, Benoit, Pierre, Nélieu, Sylvie, Labruère, Raphaël

    Published in Chemosphere (Oxford) (01-11-2022)
    “…Environmental emission of pharmaceutical pollutants notably causes the contamination of aquatic ecosystems and drinking water. Typically, reduction of these…”
    Get full text
    Journal Article
  12. 12

    Photodegradation of methotrexate in aqueous solution: degradation kinetics and identification of transformation products by Espinosa, Anaïs, Nélieu, Sylvie, Lieben, Pascale, Skarbek, Charles, Labruère, Raphaël, Benoit, Pierre

    “…Methotrexate is an antineoplastic folate analog of high environmental concern, due to its low biodegradability and toxicological properties. This study focused…”
    Get full text
    Journal Article
  13. 13

    Structural modification and biological activity studies of tagitinin C and its derivatives by Au, Thi Hang, Skarbek, Charles, Pethe, Stephanie, Labruere, Raphael, Baltaze, Jean-Pierre, Nguyen, Thi Phuong Hoa, Vu, Thi Thu Ha, Vo-Thanh, Giang

    Published in Tetrahedron (16-07-2021)
    “…The Michael addition reaction of amines, phosphonates and thiols to Tagitinin C containing in its structure an α-methylene-γ-lactone motif and two…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies by Skarbek, Charles, Delahousse, Julia, Pioche-Durieu, Catherine, Baconnais, Sonia, Deroussent, Alain, Renevret, Patrice, Rivard, Michael, Desmaele, Didier, Martens, Thierry, Le Cam, Eric, Couvreur, Patrick, Paci, Angelo

    Published in International journal of pharmaceutics (05-11-2017)
    “…[Display omitted] Oxazaphosphorines including cyclophosphamide, trofosfamide and ifosfamide (IFO) belong to the alkylating agent class and are indicated in the…”
    Get full text
    Journal Article
  16. 16

    Abstract 2194: New oxazaphosphorine prodrugs for immunotherapy and nanomedicine against cancer by Skarbek, Charles, Gonde, Henri, Desbois, Mélanie, Delahousse, Julia, Chaput-Gras, Nathalie, Benoit, Jean-Pierre, Roger, Emilie, Paci, Angelo

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Oxazaphosphorines (Oxaza) are widely used in the treatment of numerous cancers, activity against various tumor types, from soft tissue sarcomas to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development by Maslah, Hichem, Skarbek, Charles, Gourson, Catherine, Plamont, Marie‐Aude, Pethe, Stéphanie, Jullien, Ludovic, Le Saux, Thomas, Labruère, Raphaël

    Published in Angewandte Chemie (02-11-2021)
    “…Pharmacological inactivation of antitumor drugs toward healthy cells is a critical factor in prodrug development. Typically, pharmaceutical chemists graft…”
    Get full text
    Journal Article
  19. 19

    Abstract 4537: Geranyloxy-ifosfamide: A pre-activated ifosfamide analogue showing an increased therapeutic index by Skarbek, Charles, Desmaele, Didier, Deroussent, Alain, Lesueur, Lea, Daudigeos-Dubus, Estelle, Le Dret, Ludivine, Rivard, Michael, Martens, Thierry, Vassal, Gilles, Couvreur, Patrick, PACI, Angelo

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Ifosfamide (IFO) is an alkylating agent used in routine clinical practices for treatment of cancer for many years. As a prodrug it requires cytochrome P450…”
    Get full text
    Journal Article
  20. 20